These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15098092)

  • 1. [Perfusion measurement using the T2* contrast media dynamics in neuro-oncology. Physical basics and clinical applications].
    Weber MA; Risse F; Giesel FL; Schad LR; Kauczor HU; Essig M
    Radiologe; 2005 Jul; 45(7):618-32. PubMed ID: 15098092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a T1 and T2* leakage correction method based on multiecho dynamic susceptibility contrast MRI using MION as a reference standard.
    Stokes AM; Semmineh N; Quarles CC
    Magn Reson Med; 2016 Aug; 76(2):613-25. PubMed ID: 26362714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Susceptibility Contrast MR Imaging in Glioma: Review of Current Clinical Practice.
    Boxerman JL; Shiroishi MS; Ellingson BM; Pope WB
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):649-670. PubMed ID: 27742108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast MRI with and without contrast agent leakage correction in paediatric brain tumours.
    Novak J; Withey SB; Lateef S; MacPherson L; Pinkey B; Peet AC
    Br J Radiol; 2019 Feb; 92(1094):20170872. PubMed ID: 30358415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional MRI procedures in the diagnosis of brain tumors: Perfusion- and diffusion-weighted imaging].
    Hartmann M; Heiland S; Sartor K
    Rofo; 2002 Aug; 174(8):955-64. PubMed ID: 12142971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perfusion by magnetic resonance imaging: its physical foundations and clinical application].
    Fayed-Miguel N; Castillo-Blandino J; Medrano-Lin J
    Rev Neurol; 2010 Jan 1-15; 50(1):23-32. PubMed ID: 20073020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of arterial spin-labeling techniques and dynamic susceptibility-weighted contrast-enhanced MRI in perfusion imaging of normal brain tissue.
    Weber MA; Günther M; Lichy MP; Delorme S; Bongers A; Thilmann C; Essig M; Zuna I; Schad LR; Debus J; Schlemmer HP
    Invest Radiol; 2003 Nov; 38(11):712-8. PubMed ID: 14566181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary brain lymphoma and glioblastoma: evaluation of DCE T1 and DSC T2 MRI perfusion findings.
    Soydan H; Sözmen Cılız D; Cesur T; Tezgör Aksakal E
    Acta Radiol; 2024 Jul; 65(7):800-807. PubMed ID: 38798137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the Blood-Brain Barrier and Regional Perfusion in Tumor Development: MRI Insights from a Rat C6 Glioma Model.
    Huhndorf M; Moussavi A; Kramann N; Will O; Hattermann K; Stadelmann C; Jansen O; Boretius S
    PLoS One; 2016; 11(12):e0168174. PubMed ID: 28005983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttreatment DSC-MRI is Predictive of Early Treatment Failure in Children with Supratentorial High-Grade Glioma Treated with Erlotinib.
    Lucas JT; Knapp BJ; Uh J; Hua CH; Merchant TE; Hwang SN; Patay Z; Broniscer A
    Clin Neuroradiol; 2018 Sep; 28(3):393-400. PubMed ID: 28382379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of a simplified spin and gradient echo (sSAGE) approach for human brain tumor perfusion imaging.
    Stokes AM; Skinner JT; Yankeelov T; Quarles CC
    Magn Reson Imaging; 2016 Nov; 34(9):1248-1255. PubMed ID: 27457801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic susceptibility contrast MRI with a prebolus contrast agent administration design for improved absolute quantification of perfusion.
    Knutsson L; Lindgren E; Ahlgren A; van Osch MJ; Bloch KM; Surova Y; Ståhlberg F; van Westen D; Wirestam R
    Magn Reson Med; 2014 Oct; 72(4):996-1006. PubMed ID: 24285621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
    Ellingson BM; Zaw T; Cloughesy TF; Naeini KM; Lalezari S; Mong S; Lai A; Nghiemphu PL; Pope WB
    J Magn Reson Imaging; 2012 Jun; 35(6):1472-7. PubMed ID: 22281731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of BOLD cerebrovascular reactivity mapping and DSC MR perfusion imaging for prediction of neurovascular uncoupling potential in brain tumors.
    Pillai JJ; Zacà D
    Technol Cancer Res Treat; 2012 Aug; 11(4):361-74. PubMed ID: 22376130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of brain tumors by magnetic resonance dynamic susceptibility contrast perfusion-weighted imaging and computed tomography perfusion: a comparison study.
    Scola E; Desideri I; Bianchi A; Gadda D; Busto G; Fiorenza A; Amadori T; Mancini S; Miele V; Fainardi E
    Radiol Med; 2022 Jun; 127(6):664-672. PubMed ID: 35441970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
    Warmuth C; Gunther M; Zimmer C
    Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attempts to improve absolute quantification of cerebral blood flow in dynamic susceptibility contrast magnetic resonance imaging: a simplified T1-weighted steady-state cerebral blood volume approach.
    Wirestam R; Knutsson L; Risberg J; Börjesson S; Larsson EM; Gustafson L; Passant U; Ståhlberg F
    Acta Radiol; 2007 Jun; 48(5):550-6. PubMed ID: 17520432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of arteriolar blood volume in brain tumors using MRI without exogenous contrast agent administration at 7T.
    Wu Y; Agarwal S; Jones CK; Webb AG; van Zijl PC; Hua J; Pillai JJ
    J Magn Reson Imaging; 2016 Nov; 44(5):1244-1255. PubMed ID: 27028493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.